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Correlation between perceived cardiovascular risk (CVR) by physicians
and real CVR is poorly known. Moreover, the underlying question of factors
associated to risk misevaluation, especially for patients at high CVR and that
could benefit of a lipid lowering therapy (LLT), remains unsolved.
 
Objective and methodology: 
 
This was an on-line non-interventional study
conducted on a sample of 619 general practitioners. The aim was to describe
the relation between physicians evaluated CVR and calculated CVR according
to risk’s scales. All consulting patients’ aged50 years old (YO) were included.
Physicians had to complete a questionnaire and to assess patient’s CVR on a
3 level scale (low, medium, and high). Framingham and SCORE (low
risk<2%, high risk5%) were calculated. 
 
Results: 
 
13446 patients were included (mean age: 67 YO, male: 48%,
LDLc1.3g/L: 46%, LLT: 36%, personal history of CV disease: 16%, smoker:
12%, high blood pressure (HBP): 52%, diabetes: 18%). 
Physicians evaluation mismatched with Framigham for 50% of the patients
and 27% were under-evaluated. Evaluation mismatched with SCORE for 53%
of the patients, 38% were under-evaluated. Within the 25% of the patients
having a Framingham score >20% and without a lipid lowering treatment,
70% was under evaluated by physicians. Within the 38% of the patients
having a SCORE calculation 5% and without a lipid lowering treatment, 78%
were under evaluated.
 
Conclusion: 
 
This study underlines the mismatch between GP perceived
CVR and calculated CVR, especially for high CVR patient. Males, patients
with treated HBP and with high LDL-c were at increased risk of CVR under-
evaluation.
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Objective:
 
 Human immunodeficiency virus (HIV)-infected patients
receiving combined active antiretroviral therapy (cART) are at higher risk of
cardiovascular disease, due in part to metabolic complications such as lipod-
ystrophy syndrome, insulin resistance, and dyslipidemia. Whether lipodys-
trophy and cART impact on the vasculature is debated. We investigated the
impact of lipodystrophy and protease inhibitors (PIs) on aortic stiffness.
 
Methods
 
:
 
 Aortic stiffness was evaluated using carotid–femoral pulse wave
velocity (PWV) in consecutive HIV-infected patients without a history of car-
diovascular disease referred to a cardiovascular clinic.
 
Results:
 
 175 patients were enrolled (mean age 48.2 ± 8.7 years; 89% men).
Eighty six per cent of patients were receiving cART. Dyslipidemia, tobacco,
and hypertension were the most prevalent cardiovascular risk factors (39%,
38%, and 31%, respectively). Seventy-nine (45%) HIV-infected patients had
lipodystrophy and 80 (46%) were on PIs. Aortic PWV was similar in patients
with or without lipodystrophy (9.7±1.9 vs 9.8±2.5 ms
 
-1
 
, respectively; 
 
P
 
 = 0.81)
and in patients on or not on PIs (9.8±2.6 vs 9.7±1.9 ms
 
-1
 
; 
 
P
 
 = 0.71). In
univariate analysis, aortic PWV was associated with increasing age, waist/hip
ratio, systolic and diastolic blood pressures, mean arterial and pulse pressures,
but not with presence of lipodystrophy, PIs, or specific factors related to HIV
infection. Linear regression analysis showed an association between aortic
PWV and age (= 0.49, 
 
P
 
 = 0.001) and systolic arterial pressure (= 0.21, 
 
P
 
 =
0.006).
 
Conclusions:
 
 Aortic stiffness is associated with traditional cardiovascular
risk factors, particularly ageing and blood pressure. Hypertension is becoming
an emerging complication in HIV-infected patients. 
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Objectifve: 
 
To determine the prevalence of hypertension in a cohort of
HIV-infected patients (
 
HIV+).
Methods: 
 
HIV+ patients were enrolled consecutively at ambulatory cardi-
ology consultation.  We evaluated :
cardiovascular risk factors,
office blood pressure,
 
Population risk is listed below
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Explanatory factors for under-evaluation in primary prevention according to 
SCORE:
 
 OR CI 95%
Treated HBP vs no HBP
 
2,55 2.04-3.19
 
Gender (male)
 
2,44 2,16-2,76
 
Higher LDLc
 
2,13 1,78-2,55
 
Smoker
 
1,82 1,52-2,19
 
Chronic inflammatory disease
 
1,19 1,00-1,42
 
Age
 
1,16 1,15-1,17
 © Elsevier Masson SAS. All rights reserved.
 
 
Archives of Cardiovascular Diseases Supplements (2011) 3, 72-78 75
 
24 hours ambulatory blood pressure monitoring (ABPM).
We identified patients with known hypertension, masked hypertension and
white-coat effect.  
 
Results: 
 
258 HIV+ patients (mean age
 
 
 
49 ± 7 ans, 91% men)
 
 
 
were consec-
utively included in this study between 2005 and 2009. Cardiovascular risk fac-
tors were as follows: 52% had dyslipidemia, 51% were active smokers, 40%
with known hypertension and 9 % were diabetics. Body mass index of the
entire cohort was 24 ± 4 kg/m
 
∑
 
 and 89% were under antiretrovirals. Data on
blood pressure are depicted in Table 1. 19% (29) were discovered to have
hypertension. 
 
Conclusion: 
 
Hypertension is frequent in HIV-infected patients and more
and more common with aging. The number of non-dipper HIV+ was high in
this cohort. Studies on the impact of HIV infection and antiretrovirals on the
autonomic nervous system should be performed.  
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Background:
 
 Abdominal aortic aneurysm (AAA) remains asymptomatic
for many years but often revealed dramatically (inaugural rupture). Its rela-
tively low prevalence in the general population (5.5% of men over 65 years)
implies specific target population screening. Patients with acute myocardial
infarction (AMI) represent a high-risk population in which screening for other
atherosclerotic locations is recommended but is still often neglected. We
aimed to evaluate the feasibility of AAA screening during routine transtho-
racic echocardiography (TTE) in patients with AMI using a portable echocar-
diography system and to determine the prevalence of AAA in this population. 
 
Methods:
 
 We prospectively measured the size of the abdominal aorta at
the end of a regular TTE performed at bedside in consecutive patients
admitted for AMI in our intensive care unit using a portable TTE system
(Vividi, General electric). AAA was defined by a transverse diameter  30 mm. 
 
Results:
 
 One hundred and fifty two patients were enrolled (mean age
65±14 years old, 78% of male). Measurement of the size of the abdominal
aorta was feasible in 93% (10 patients had poor echogenicity) and time dura-
tion was 3±1min. Interobserver variability between cardiologists was good
(1.7±1mm). Eight patients had an AAA (5.2%) and prevalence increases with
age, 8.7 % after 60 years, 10.3% after 65 years. No patient below 50 years old
had an AAA.
 
Conclusion:
 
 In patients admitted for AMI, screening for AAA during TTE
using a portable TTE system was fast and highly feasible. Despite a striking
low prevalence of AAA in this high cardiovascular risk population, analyse of
the abdominal aorta should be recommended during TTE ("one cardiovascular
shot") especially in elderly patients in regard to the simplicity, inocuity and
availability of the present screening.
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Introduction: 
 
Lower-extremity peripheral artery disease (PAD) is associ-
ated with traditional cardiovascular disease risk factors (smoking, hyperten-
sion, dyslipidemia, diabetes). Among participants in the Multi-Ethnic Study of
Atherosclerosis (MESA), we sought to assess the prevalence of PAD in a pop-
ulation without these risk factors. We hypothesized that this prevalence is not
negligible, and that in this situation, PAD would still remain associated with
other measures of subclinical atherosclerosis.
 
Methods:
 
 In the MESA cohort, we selected those (n=1932) meeting the
following criteria: no smoking over the last 10 years, no history of hyperten-
sion, dyslipidemia or diabetes, and normal blood pressure (140/90), fasting
blood glucose 1.26 g/l, and a total-/HDL-cholesterol ratio <5. Participants
were classified according to their ankle-brachial index (ABI) into 3 groups:
low (<1.00), normal (1.00-1.30) and high (>1.30) ABI. Measures of subclin-
ical atherosclerosis included any coronary artery calcification (CAC) or carotid
plaque.
 
Results:
 
 Overall, the mean estimated Framingham risk score for coronary
heart disease was 0.61% /year. Low- and high ABI were found in 176 (9%)
and 149 (7.8%) participants, respectively. In multivariable models including
age, gender and ethnicity, lower glomerular filtration rates (OR: 0.88 /10 units,
p=0.04) and higher interleukin-6 levels (OR:1.42 /natural-log unit, p=0.02)
were associated with low ABI. Higher body-mass index (OR:1.07 /unit,
p<0.001) was associated with high ABI. In a fully-adjusted model, low-ABI,
not high-ABI, was significantly associated with CAC prevalence (OR:1.22,
p<0.03). No significant association was found with carotid plaque.
 
Conclusion:
 
 In subjects without traditional risk factors, PAD is common.
Such persons remain at higher risk for coronary artery disease.
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Background
 
: Ambulatory blood pressure monitoring (ABPM), while used
routinely in Hypertension, has rarely been applied in Chronic Heart Failure
(CHF). This study was designed to assess prognostic value of ABPM data in
our patients with CHF.
Parameters N= 258
Office systolic BP, mmHg 131 ± 19
Office diastolic BP, mmHg 81 ± 10
Mean 24h-systolic BP, mmHg 125 ±13
Mean 24-diastolic BP, mmHg 77 ± 9
Daytime systolic BP, mmHg 129 ± 13
Daytime diastolic BP, mmHg 80 ± 9
Nighttime systolic BP, mmHg 115 ± 17
Nighttime diastolic BP, mmHg 68 ±10
BP profile in known hypertensive patients N= 103
Number of patients with appropriate BP control, % 45%
Number of patients with white-coat effect, % 17%
Non dipper, % 43% in known 
hypertensive patients 
39% in unknown 
hypertensive patients 
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